VYNE Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of VYNE for the last quarter is 76.00 k USD, and it's 33.33% lower compared to the previous quarter. The net income of Q4 23 is -6.19 M USD.